Peptides for pain sensation and peptides for pain relief

For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Skip to main content Skip to article

View PDF

Under a Creative Commons license

Open access

Highlights

•
Endogenous excitatory and inhibitory peptides regulate pain through complex signaling cascade mechanisms.
•
The mechanism of pharmacological action of endogenous and exogenous peptides relating to pain is summarized.
•
The peptide treatments target pain by enhancing analgesic pathways or blocking harmful algesic mechanisms are discussed.
•
Future work should focus on discovering peptide-based drugs to treat pain and overcome limitations of current analgesics.

Abstract

Peptides play crucial roles in pain regulation. Following tissue injury or insults, many endogenous excitatory peptides, such as calcitonin gene-related peptide, substance P, nerve growth factor, bradykinin, hemokinin-1, cholecystokinin, and endothelin, are generated, which are eventually responsible for pain sensation. To alleviate pain physiologically, many endogenous inhibitory peptides are generated, including opioid peptides, neuropeptide Y, oxytocin, and orexin A. As peptides can induce pain, the use of pain-alleviating peptides is like fighting fire with fire. Although increasing evidence has revealed new mechanisms of peptides in the transmission and perception of pain, comprehensive descriptions regarding how endogenous peptides modulate pain are lacking. This review describes the role of endogenous peptidergic pathways in pain processing, persistence, and resolution. Targeting endogenous peptides by activating inhibitory pathways or antagonizing excitatory pathways might be a promising natural way to alleviate pain. This review also focuses on peptide-associated pathways and the therapeutic applications of peptides that reduce pain in the treatment of various diseases. Additionally, we sought to investigate peptide-based target-specific drug discovery to treat pain-related disorders.

Keywords

Endogenous peptides

Excitatory peptides

Inhibitory peptides

Pain

Analgesia

Data availability

No data was used for the research described in the article.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Key takeaways

NF-kB pathway anti-inflammatory peptides inhibit inflammation upstream by preventing IκB degradation, keeping transcription factors sequestered in the cytoplasm before pro-inflammatory genes activate.
IKK inhibitory peptides, which block the kinase that phosphorylates IκB, demonstrate 54–63% reductions in cytokine secretion without impairing T-cell or B-cell function in preclinical models.
Cyclisation and D-amino acid substitution extend peptide half-life from under 2 hours to 6.8 hours, enabling once-daily dosing in chronic inflammation contexts.
Cell-penetrating peptide (CPP) conjugation. Using sequences like TAT or penetratin. Achieves 72% cytoplasmic delivery efficiency, solving the primary bioavailability challenge for peptide therapeutics.
NF-kB pathway anti-inflammatory peptides preserve antimicrobial immunity and vaccine responses, offering a therapeutic profile distinct from corticosteroids or TNF-α blockers.

realpeptides.co

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Highlights

Abstract

Keywords

Data availability

Peptide Therapy Guide Editorial Team

Peptides | Pain Management Therapy | Cherry Hill, New Jersey

6 Peptide Therapy Benefits That Will Transform Your Health

Peptides: Types, Uses, and Benefits

Peptide Therapy for Inflammation: A New Solution